Browsing Tag
hVIVO
3 posts
hVIVO (AIM: HVO) wins world-first Phase III whooping cough challenge trial contract with ILiAD Biotechnologies
hVIVO (AIM: HVO) signs its largest human challenge trial contract with ILiAD Biotechnologies for a world-first pivotal Phase III pertussis vaccine study. Read what it means for investors.
hVIVO expands biopharma capabilities with Cryostore acquisition
hVIVO plc has completed the acquisition of Cryostore Limited, a specialist provider of temperature-controlled storage solutions, in a…
hVIVO engages in major phase 2b influeness drug study as exclusive UK clinical site
hVIVO plc (AIM & Euronext: HVO), a rapidly expanding specialist contract research organisation (CRO) renowned for its expertise…